Revenio Group Corporation : Revenio Group Corporation: FINANCIAL STATEMENTS BULLETIN, JANUARY 1 - DECEMBER 31, 2012 - HEALTH

 Revenio Group Corporation : Revenio Group Corporation: FINANCIAL STATEMENTS
  BULLETIN, JANUARY 1 - DECEMBER 31, 2012 - HEALTH TECH SURGING - CHANGE IN
                       STRATEGY SUPPORTS GROWTH TARGETS

Revenio Group Corporation    Stock Exchange Release, February 8, 2013 at
9:00 a.m.

REVENIO GROUP CORPORATION'S FINANCIAL STATEMENTS BULLETIN, JANUARY 1 -
DECEMBER 31, 2012 - HEALTH TECH SURGING - CHANGE IN STRATEGY SUPPORTS GROWTH
TARGETS

Highlights for the period:

  *The Revenio Health Tech segment performed excellently in terms of both net
    sales and profitability. Sales were particularly strong in North America
    and Asia.

  *The Revenio Technology and Services segment improved its result,
    especially thanks to the good trend in the Information Displays and
    Software businesses; the Contact Center business also posted growth.

  *Both the strategy and organization were changed to support growth,
    effective as from December 1, 2012.

  *The decision to divest the Done Logistics business was made on December
    18, 2012; provisions for expenses associated with winding up the business
    are recognized in the result for discontinued operations in Q4/2012.

  *The proposed dividend is EUR 0.02 (0.02) per share. In addition, an
    authorization for a capital repayment of EUR 1,000,000.00 at the maximum
    will be proposed.

Group key figures:

  *Consolidated net sales amounted to EUR 25.4 million (EUR 21.4 million), up
    18.3 percent. 

  *Consolidated operating profit was EUR 4.9 million (EUR 3.3 million), or
    19.4 (15.6) percent of net sales.

  *The net sales of the Revenio Health Tech segment amounted to EUR 11.1
    million (EUR 8.9 million), up 23.8 percent.

  *The operating profit of Revenio Health Tech segment was EUR 4.4 million
    (EUR 3.5 million), representing 40.0 (38.7) percent of net sales, an
    increase of EUR 0.9 million.

  *The net sales of the Revenio Technology and Services segment came to EUR
    14.3 million (EUR 12.5 million), up 14.4 percent. 

  *The operating profit of Revenio Technology and Services was EUR 1.5
    million (EUR 0.7 million), representing 10.2 (5.6) percent of net sales,
    an increase of EUR 0.8 million.

  *Net result from discontinued operations was EUR -4.8 million (EUR 1.8
    million), consisting of the earnings of Done Logistics and provisions for
    expenses associated with winding up its business. The figures for the
    reference period include capital gains from the divestment of Done
    Information in 2011.

  *For continuing operations, undiluted earnings per share came to EUR 0.059
    (0.028) and diluted earnings per share to EUR 0.059 (0.027).

  *Cash flow from operating activities amounted to EUR 0.8 million (EUR 4.2
    million).
    

  *Financial guidance for 2013: In continuing operations, net sales and
    operating profit excluding non-recurring items are expected to see
    year-on-year growth.

OCTOBER-DECEMBER/2012

  *Consolidated net sales amounted to EUR 7.7 million (EUR 5.7 million), up
    34.9 percent. 

  *Consolidated operating profit was EUR 1.4 million (EUR 0.7 million), or
    18.2 (13.1) percent of net sales.

  *The net sales of the Revenio Health Tech segment amounted to EUR 3.2
    million (EUR 2.6 million), up 23.1 percent.

  *The operating profit of Revenio Health Tech segment was EUR 1.2 million
    (EUR 1.1 million), representing 35.8 (38.5) percent of net sales, an
    increase of EUR 0.1 million.

  *The net sales of the Revenio Technology and Services segment came to EUR
    4.5 million (EUR 3.0 million), up 46.7 percent.

  *The operating profit of Revenio Technology and Services segment was EUR
    0.5 million (EUR 0.1 million), representing 10.9 (3.3) percent of net
    sales, an increase of EUR 0.4 million.

President and CEO Olli-Pekka Salovaara:
"2012 was a significant year for Revenio Group. At the end of the year, we
kicked off a strategy overhaul geared toward supporting measures to bolster
strong growth in health technology. Our target in the health technology sector
is to buildIcareinto the leading global player in tonometers used in
screening for intraocular pressure.

This change process began on December 1, 2012, when the Group's business
operations were divided into two business units and reporting segments. The
operations of the Revenio Health Tech segment comprise the business operations
of Icare Finland Oy and some of the parent company's functions. I am
responsible for this segment in addition to my other duties. The Revenio
Technology and Services segment comprises the Software business (Done Software
Solutions Oy), the Information Displays business (FLS Finland Oy), the Rigid
Inflatable Boats business (Boomeranger Boats Oy), the Contact Center business
(Midas Touch Oy) and some of the functions of the Group's parent company. In
December, we announced that we will divest the operations of the Group's
company Done Logistics Oy. Riku Lamppu has been appointed to head up the
segment.

Our financial objective for 2012 was to grow both net sales and profitability
in which we succeeded in continuing operations. Further bolstering the net
sales and profitability of the Health Tech segment was vitally important from
the perspective of our strategic choices. Both the Software and Information
Displays businesses saw excellent growth and profitability development. The
strong growth in the order book of the Rigid Inflatable Boats business was
also a commendable achievement. Delightfully, the Contact Center business
continued to develop surely and steadily.

Health technology is a growing and profitable business for Revenio. Of
Revenio's businesses, Icare Finland, which focuses on health technology, has
achieved the best growth in profitability and net sales in both the short and
long term. The company has accumulated a wealth of in-house expertise - and we
now seek to harness it. Thanks to our expertise in technology, we have become
the international product and cost leadership in tonometers. Our international
distribution network is highly effective, both operationally and financially.
We are very knowledgeable in official approval processes in different
countries. By focusing our resources on this highly developed and promising
business area, we are building a strong growth path for Revenio Group."

MARKET SITUATION

REVENIO HEALTH TECH

The Revenio Health Tech segment comprises Icare Finland Oy, the managing
director of which is Timo Hildén, which specializes in the development,
manufacture and sale of tonometers, as well as some functions that were
previously part of the Group's parent company. Olli-Pekka Salovaara, the
Group's President and CEO, heads up this business segment in addition to his
other tasks.

The Revenio Health Tech segment had a good market situation during the entire
financial year, and demand for its products grew substantially. The segment's
current main markets are in North America, Europe, Russia and selected Asian
countries, such as Japan and India. Thanks to the geographical structure of
its sales and the growing demand for its products, the segment's business
operations were not hindered by macroeconomic challenges, except in southern
European countries. There are a number of markets with major demand potential
that the company has not tapped into yet - particularly South America and
China.

The bulk of current demand focuses on the first-generation Icare TA-01
tonometer. One key part of a tonometer is a disposable probe. Demand for these
probes increased substantially - and is expected to rise further in step with
the growth of the tonometer customer base. New emerging product groups are the
Icare Pro for specialist physicians and the Icare One self-tonometry device.
The latter device, intended for self-administered measurements at home, has
performed extremely well in medical studies on glaucoma treatment carried out
by many leading ophthalmologists. These studies are expected to influence the
development of glaucoma monitoring and treatment practices in the future,
which in turn will serve to improve demand for Icare tonometers.

It is estimated that more than 150 million people worldwide suffer from
glaucoma and that only about half of them have been diagnosed with the
disease. As healthcare systems develop, screening for glaucoma will become
more common. Traditionally, examinations for eye diseases have been the domain
of specialists. Icare's patented measuring technology enables mass screening.
As this becomes common, intraocular pressure measurements can also be
performed by general practitioners, optometrists, opticians and first-aid
station staff. This will give Icare the opportunity to expand its customer
base. Legislation on intraocular pressure measurement varies from country to
country. For this reason, Icare's global distribution network has been set up
to serve exactly the right target group in each country within the framework
of local legislation.

Icare's measurement system has been extensively patented. The strongest
competitors are alternative technologies developed by competitors. The Icare
product family's advantages are technology and cost leadership.

Icare tonometers can also be used to measure the intraocular pressure of
animals. This target group also presents an attractive opportunity for
broadening Icare's customer base.

Icare's market position can be bolstered further by developing product
features. Development measures were launched during the review period with a
view to retaining the company's competitive advantage and generating revenue
from replacement purchases by customers seeking to update their devices. As
the customer base grows, so will the demand for productized maintenance
services.

REVENIO TECHNOLOGY AND SERVICES

On December 1, 2012, the Revenio Technology and Services segment was formed
from four Group businesses and companies and some functions of the Group's
parent company. Riku Lamppu was appointed as the head of this segment. He is
also the CEO of Midas Touch Oy, which is part of this segment.

The businesses included in this segment are Software (Done Software
Solutions), Contact Center (Midas Touch), Information Displays (FLS Finland)
and Rigid Inflatable Boats (Boomeranger Boats).

Contact Center business

The market situation of the Contact Center business remained good during the
financial period. Market growth in this business was restrained, but the
number of inbound commissions - which are a core expertise area for the
segment - is on the rise. This paves the way for steady growth and enables
business operations to focus on outsourcing solutions for technical customer
support and other expert services. The market situation for outbound
commissions, such as telemarketing campaigns, was more challenging from a
profitability perspective. The market situation is also affected by the
availability of suitable staff for support tasks in the business localities,
which was satisfactory in the Contact Center business during the review
period.

Rigid Inflatable Boats business

The market situation for rigid inflatable boats and outlook for their demand
improved slightly during the review period, in part due to the expansion of
tendering and customer orders to new customer accounts in different
geographical areas and user groups. New customer relationships with the
authorities were forged in countries such as Malta and the Netherlands. The
general economic situation in European countries did not affect the number of
state defense and rescue projects. When the Rigid Inflatable Boats business is
vying for projects, its competitors are often the same leading players -
especially when these projects are large. Disputes concerning public
procurement decisions have become more common, reflecting the tough
competition between the leading players in this field. This slows down
dealings somewhat in the Rigid Inflatable Boats business.

Information Displays business

The market situation for LED price displays was good, enabling the business to
post its best-ever annual sales. Demand primarily comprises small-scale
projects carried out on short schedules. Demand for procurements related to
BP's multi-year framework agreement developed favorably, as did demand in new
market areas such as Russia. Of the traditional market areas, demand was good
in Sweden and Finland. Demand for parking guidance systems was very modest.

Software business

The market situation of the Software business was good. Demand is affected by
gaining new customer projects and their scheduling. Carrying out pilot
projects for large customer corporations may create market potential for
larger-scale deployment projects in the future. The expansion of the installed
software base also increases the amount of small-scale development and
maintenance work. Competition for projects is considerable.

NET SALES, PROFITABILITY AND PROFIT

Consolidated net sales from Revenio Group's continuing operations for the
period from January 1 to December 31, 2012 were EUR 25.4 million (EUR 21.4
million), showing an increase of 18.3 percent. Earnings before interest,
taxes, depreciation and amortization (EBITDA) from continuing operations
amounted to EUR 5.7 million (EUR 4.0 million), or 22.5 (18.8) percent of net
sales. Consolidated operating profit (EBIT) from continuing operations was EUR
4.9 million (EUR 3.3 million), representing 19.4 (15.6) percent of net sales.
The pre-tax result totaled EUR 4.7 million (EUR 3.0 million), or 18.5 (14.0)
percent of net sales. For continuing operations, consolidated net profit for
the financial year amounted to EUR 4.6 million (EUR 2.1 million), representing
18.0 (9.9) percent of net sales. Net profit for discontinued operations during
the financial year totaled EUR -4.8 million (EUR 1.8 million). Profit for the
financial year totaled EUR -0.3 million (EUR 3.9 million).

Undiluted earnings per share for continuing operations totaled EUR 0.059
(0.028), while dilution-adjusted earnings per share came to EUR 0.059 (0.027).
For discontinued operations, the undiluted and diluted earnings per share
totaled EUR -0.063 (0.023). Dilution-adjusted earnings per share for
continuing and discontinued operations during the financial year totaled EUR
-0.004 (0.050). Equity per share was EUR 0.19 (0.21).

The net sales of continuing operations in Q4 came to EUR 7.7 million (EUR 5.7
million). Net sales were up 34.9 percent. Consolidated operating profit for Q4
from continuing operations amounted to EUR 1.4 million (EUR 0.7 million), or
18.2 (13.1) percent of net sales. The undiluted and diluted earnings per share
from continuing and discontinued operations in Q4 totaled EUR -0.008 (0.003).

In 2012, net sales of the Group's continuing operations grew 18.3 percent
year-on-year. Substantial net sales growth was seen in the Revenio Health Tech
segment as well as in the Information Displays and Software businesses of the
Revenio Technology and Services segment. In this segment, the Contact Center
business also achieved profitable growth in operations. The net sales of the
Rigid Inflatable Boats business declined due to the timing of orders and
production.

Both business segments posted higher operating profit than in the previous
year.

On December 18, 2012, the Group decided to divest the Done Logistics Oy
business. As from that day, the company has been classified under discontinued
operations in consolidated reporting. This change in reporting also applies to
the reference years. The net profit of discontinued operations in the 2012
financial year consists of the net profit of Done Logistics Oy, a provision
for the expenses related to winding up operations and a write-down of the
additional sale price receivable from the divestment of Done Information Oy.

BALANCE SHEET, FINANCIAL POSITION AND INVESTMENTS

The consolidated balance sheet total on December 31, 2012 was EUR 25.0 million
(EUR 24.8 million). Shareholders' equity came to EUR 14.7 million (EUR 16.4
million). At the end of the financial year, interest-bearing net liabilities
totaled EUR -1.8 million (EUR -2.8 million) and gearing stood at -12.2 (-17.3)
percent. The consolidated equity ratio was 62.2 (66.6) percent. The Group's
liquid assets amounted to EUR 5.0 million (EUR 4.4 million) at the end of the
financial year.

Thanks to good financial development, the Group's financial position remained
stable throughout the financial year. During the financial year, the Group
withdrew a EUR 2.0 million standby-by credit and made arrangements for a EUR
2.0 million credit facility to replace the Group's checking account facility.

Cash flow from operating activities came to EUR 0.8 million (EUR 4.2 million).
Cash flow was increased by the profitability of continuing operations and
decreased by the profitability of discontinued operations and capital tied in
operations.

The Group's purchases of PPE and intangible assets totaled EUR 0.3 million
(EUR 0.7 million). These investments were earmarked for production equipment,
information technology and software.

GROUP STRUCTURE

At the end of the financial year, Revenio Group comprised parent company
Revenio Group Corporation and its wholly owned subsidiaries, all active
companies: Midas Touch Oy, Done Logistics Oy, Done Software Solutions Oy,
Icare Finland Oy, Boomeranger Boats Oy, and FLS Finland Oy. Done Logistics Oy
has been categorized under discontinued operations.

In order to improve the effectiveness of the Group structure, the subsidiaries
of Midas Touch Oy - Midas Touch Media Oy, Midas Touch Gateway Oy, Midas Touch
Interactive Oy, Midas Touch Tech Oy, and Midas Touch Care Oy - were merged
into their parent company on February 29, 2012.

OPERATIONS BY BUSINESS SEGMENT

Revenio Group Corporation's business operations are organized into two
segments: Revenio Health Tech (Icare Finland) and Revenio Technology and
Services (Midas Touch, Done Software Solutions, Boomeranger Boats, and FLS
Finland). At the end of the financial year, Done Logistics was categorized
under discontinued operations. The structure is in line with the Group's
organization and internal reporting.

Revenio Health Tech

The Revenio Health Tech segment comprises Icare Finland, which specializes in
the development, manufacture and sale of tonometers, as well as some functions
that were previously part of the Group's parent company. Olli-Pekka Salovaara,
the Group's President and CEO, heads up this business segment in addition to
his other tasks.

In 2012, net sales of the Health Tech segment totaled EUR 11.1 million (EUR
8.9 million), up 23.8 percent. The operating profit of the Health Tech segment
amounted to EUR 4.4 million (EUR 3.5 million). Q4 net sales came to EUR 3.2
million (EUR 2.6 million) and operating profit to EUR 1.2 million (EUR 1.1
million).

As in earlier financial years, net sales and operating profit saw substantial
growth. In geographical terms, net sales growth was generated primarily by the
markets of the USA, Japan, the UK, Australia, Russia, India, Canada, Norway
and the Netherlands.  The bulk of product sales comprised the Icare TA01
tonometer, the company's main product, and its disposable probes, which saw
substantial growth in demand. The new products Icare One and Icare Pro are in
the first stages of their life cycle. Their sales growth was in line with
other sales trends. The US subsidiary that went into business in 2012
performed excellently in meeting its sales and operational targets.

During the financial year, the company achieved additional visibility in
ophthalmology research and among the field's leading researchers. Icare
products were used in many major medical studies on glaucoma treatment and the
development of treatments.

Country-specific sales licenses play a key role in global tonometer sales.
During the review period, the company obtained a total of 28 new sales
licenses in different countries. These licenses lay the foundation for the
future sales development of new products in particular. The processing of
sales licenses in the USA was slower than anticipated. The license process for
Icare One was suspended for additional preparatory work. It is expected that
the sales license application will be resubmitted in 2013.

A new CEO took the helm at Icare Finland Oy during the review period. The
previous CEO, Ari Tiukkanen, took up a position at another company. The new
CEO is Timo Hildén, M.Econ, who has extensive work experience in management
positions in the healthcare industry. Prior to joining Icare Finland Oy, he
worked as Thermo Fisher Scientific Oy's CEO and director of global business
for liquid handling instruments.
Icare's export and R&D resources were bolstered during the financial year.
The company has launched projects to develop its current products with a view
to maintaining and enhancing their competitiveness in the years ahead. Quality
processes and procurements were developed further. Strategic work related to
Icare's growth opportunities as part of the healthcare segment was started up.
The projects aim to ensure further business growth and create new growth
opportunities.

The trend in the Revenio Health Tech segment's operating profit was favorable.
Thanks to the good development of net sales, the aforementioned development
measures did not burden profitability. In 2013, the Revenio Health Tech
segment will increase its outlays on development in order to pave the way for
growth in future financial periods.

Revenio Technology and Services

On December 1, 2012, the Revenio Technology and Services segment was formed
from four Group businesses and companies and some functions of the Group's
parent company. Riku Lamppu was appointed as the head of this segment. He is
also the CEO of Midas Touch Oy, which is part of this segment.

The businesses included in this segment are the Software business (Done
Software Solutions), Contact Center business (Midas Touch), Information
Displays business (FLS Finland), and Rigid Inflatable Boats business
(Boomeranger Boats).

In 2012, the segment had net sales of EUR 14.3 million (EUR 12.5 million) and
operating profit of EUR 1.5 million (EUR 0.7 million). Q4 net sales came to
EUR 4.5 million (EUR 3.0 million) and operating profit to EUR 0.5 million (EUR
0.1 million).

Net sales saw substantial growth in the Information Displays business and the
Software business, both of which posted their best-ever net sales. Net sales
also rose in the Contact Center business thanks to growth in inbound
commissions. Net sales declined in the Rigid Inflatable Boats business.

Net sales of the Information Displays business grew because exports more than
doubled compared with the previous year. Sales also grew in Finland. The
largest share of exports went to the Nordic countries, particularly Sweden,
and to continental Europe, especially Germany. Sales to Russia, a new export
country, were started.

Growth in the Software business was mainly due to projects carried out for two
major Finnish listed companies, higher income from maintenance fees and
small-scale development work for existing customers.

The strategy of the Contact Center business has been to increase the share of
operations accounted for by inbound commissions, as the outlook for such
commissions is more stable and they pose smaller trade cycle and business
risks. Inbound operations include, for example, solutions for technical
customer services and outsourced customer services. On the whole, net sales
grew as the number of inbound commissions rose and the number of outbound
commissions declined.

The net sales of the Rigid Inflatable Boats business saw a year-on-year
decline due to the slow order inflow in the first half of the year. The
business gained significant orders in the second half, which will have a
favorable effect on net sales in 2013. Major orders were received from both
existing and new customers and geographical areas, which is in line with the
business strategy.

The major factors behind growth in the segment's operating profit were the
excellent profitability trends of the Information Displays and Software
businesses and the growth in the profitability of the Contact Center business.
In all these businesses, the profitability trend was driven by net sales
growth and very moderate cost development. Profitability went into the red in
the Rigid Inflatable Boats business, as orders materialized mainly in the
latter half of the year, and sales efforts were targeted at this financial
period.

Net sales and segment's margin excluding
non-recurring items were as follows:
                                                     Segment       Segment
                                                      profit        profit
               Net Sales         Net Sales            margin        margin
               1-12/2012         1-12/2011         1-12/2012     1-12/2011
                    MEUR  share       MEUR  share       MEUR  %       MEUR   %
Revenio                                                      40             39
Health Tech         11.1   44 %        8.9   42 %        4.4  %        3.5   %
Revenio
Technology
and
                                                             10
Services            14.3   56 %       12.5   58 %        1.5  %        0.7 6 %
                                                             23             19
Total               25.4  100 %       21.4  100 %        5.9  %        4.2   %
Parent
company
expenses                                                -1.0          -0.8
Operating
Profit, Group                                                19             16
Total                                                    4.9  %        3.3   %

The Group's net sales and operating profit from continuing operations by
segment and quarter:  

The net sales, margin, and profit, by segment
and quarter
, excluding non-recurring items, were as
follows:
          MEUR           Q4/12    Q3/12    Q2/12 Q1/12 Q4/11 Q3/11 Q2/11 Q1/11
Net sales:
Revenio Health Tech        3.2      2.6      2.6   2.6   2.6   1.9   2.2   2.3
Revenio Technology
and Services               4.5      3.4      3.2   3.2   3.0   2.8   3.4   3.3
Total                      7.7      6.1      5.8   5.8   5.6   4.7   5.6   5.6
Segment profit margin:
Revenio Health Tech        1.2      1.0      1.0   1.2   1.1   0.8   0.8   0.9
Revenio Technology
and Services               0.5      0.5      0.2   0.3   0.1   0.2   0.3   0.2
Total                      1.7      1.6      1.3   1.5   1.2   1.0   1.1   1.0
Parent co. expenses       -0.2     -0.2     -0.2  -0.3  -0.2  -0.2  -0.2  -0.2
Operating profit           1.4      1.4      1.0   1.1   1.0   0.8   0.8   0.8
Operating profit-%          18       22       17    20    18    17    15    15

HUMAN RESOURCES

In 2012, the number of personnel employed by the Group averaged 198 (201) in
continuing operations. At the end of the period, the number of employees was
220 (215). The average age of staff was 40 years (41 years).

An occupational wellbeing survey of all Group employees was carried out at the
end of the financial year. Compared to the previous survey carried out in
2010, the results improved almost across the board. The personnel and
leadership development measures to be taken on the basis of the survey results
will be specified and implemented in 2013.

The number of personnel employed by the Group during the financial year, by
segment, averaged:

Average no. of employees by segments:
                    31 Dec. 2012  31 Dec. 2011 Change
Revenio Health Tech           13            13      0
Revenio Technology
and Services                 181           184     -3
Parent Company                 4             4      0
Group Total                  198           201     -3

Wages, salaries, and other remuneration paid during the financial year totaled
EUR 6.9 million (EUR 6.6 million) in continuing operations.

MANAGEMENT

Olli-Pekka Salovaara is the President and CEO of Revenio Group Corporation.
The Management Group consists of Olli-Pekka Salovaara, President and CEO,
Riku Lamppu, head of Revenio Technology and Services, Juha Kujala, Development
Director, and Pekka Raatikainen, CFO.

The CEOs of the Group's subsidiaries are Timo Hildén (Icare Finland), Riku
Lamppu (Midas Touch), Helena Korte (FLS Finland), Jussi Mannerberg
(Boomeranger Boats), Riku Lamppu (Done Logistics) and Ari Suominen (Done
Software Solutions). Riku Lamppu serves as the CEO of Done Logistics, which is
categorized under discontinued operations, in addition to his other duties.

SHARES, SHARE CAPITAL AND MANAGEMENT HOLDINGS

On December 31, 2012, Revenio Group Corporation's fully paid-up share capital
registered with the Trade Register was EUR 5,314,918.72 and the number of
shares outstanding totaled 76,929,730.

The company has one series of shares. All shares confer the same voting rights
and an equal right to dividends and the company's funds.

On December 31, 2012, the Board of Directors and the President and CEO held
1.9 percent of the company's shares, totaling 1,499,267 shares, and 18.6
percent of the option rights, for a total of 684,365 options.

CHANGES IN SHAREHOLDING

On October 10, 2012, the company was informed that Jyri Merivirta's holding of
Revenio Group Corporation shares and votes had declined to under
three-twentieths (3/20). Merivirta now holds 13.00 percent of Revenio Group
Corporation's shares and votes, and owns 10,000,000 shares in the company.

On October 29, 2012, Eyemaker's Finland Oy notified the company that its
holding of Revenio Group Corporation shares and votes had declined to under
one-tenth (1/10). Eyemaker's Finland Oy now holds 6.50 percent of Revenio
Group Corporation's shares and votes, and owns 5,000,000 shares in the
company.

PURCHASE OF OWN SHARES

The company did not buy back any of its own shares during the financial year.
Of the 322,610 treasury shares acquired in 2011 that were held by the company
at the beginning of the financial year, 226,667 were used for the payment of
Board emoluments in accordance with the decision taken by the general meeting
of shareholders on March 28, 2012. The Board members - Rolf Fryckman, Matti
Hyytiäinen, Julia Ormio and Pekka Tammela - each received 40,000 shares in
Board emoluments. Timo Mänty, the chairman of the Board, received 66,667
shares in Board emoluments.

At the end of the financial year, the company held a total of 95,943 of its
own shares.

OPTION RIGHTS

On the basis of the share issue authorization approved by the Annual General
Meeting on April 3, 2007, the Board of Revenio Group Corporation decided, on
November 23, 2007, on a new corporate option plan, comprising a maximum of
3,684,365 option rights. Each option right entitles the holder to subscribe to
one Revenio Group Corporation share. Against the total number of the company's
shares on December 31, 2012, the proportion of shares to be subscribed for on
the basis of the option rights issued represents a maximum of 4.7 percent of
the company's shares and votes, once all new shares subscribed for with these
option rights have been registered.

Share subscriptions via the option program entitle the holder to a dividend
from the subscription year onwards.

The option rights have been divided into three series: Series A (1,684,365
shares), Series B (1,000,000) and Series C (1,000,000). The subscription
periods for options are as follows: Series A, May 1, 2009 - May 1, 2013,
Series B, November 1, 2010 - November 1, 2014, and Series C, May 1, 2012 - May
1, 2016. The share subscription price will be the trade-weighted average price
during the periods November 1-30, 2007 (EUR 0.62, Series A), April 1-30, 2009
(EUR 0.27, Series B) and November 1-30, 2010 (EUR 0.26, Series C).

No new options were granted to employees during the period. During the period,
a total of 40,000 new shares were subscribed under 2007C series options. The
increase in the share capital was entered in the Trade Register on October 3,
2012. Proceeds from the share subscription were booked in their entirety in
the invested unrestricted equity reserve.

TRADING ON THE NASDAQ OMX HELSINKI

During the period January 1 - December 31, 2012, Revenio Group Corporation's
turnover on the NASDAQ OMX Helsinki exchange totaled EUR 13.6 million (EUR
17.3 million), representing 32.7 (39.4) million shares or 42.5 (51.2) percent
of shares outstanding. The trading high was EUR 0.50 (0.62) and the low EUR
0.33 (0.30). At the end of the review period, the closing price was EUR 0.40
(0.48), and the average share price EUR 0.42 (0.44). Revenio Group
Corporation's market value on December 31, 2012, was EUR 30.8 million (EUR
36.9 million).

ANNUAL GENERAL MEETING AND BOARD AUTHORIZATIONS IN EFFECT

The Annual General Meeting held on March 28, 2012 approved the company's
financial statements and discharged the members of the Board of Directors and
the President and CEO from liability for the financial year January 1 -
December 31, 2011.

The AGM re-selected the following persons as members of the Board of
Directors: Timo Mänty, Pekka Tammela, Rolf Fryckman, Julia Ormio and Matti
Hyytiäinen. The AGM decided that the Chairman of the Board should be entitled
to an annual emolument of EUR 60,000 and the other Board members to an annual
emolument of EUR 36,000, with the exception that any member who holds a stake
of at least five percent in Revenio Group Corporation, either directly or
through a company in which he or she has a minimum holding of 50 percent,
should not be entitled to a separate emolument. In total, 40 percent of Board
members' emoluments will be settled in the form of shares in the company,
while 60 percent will consist of monetary payment.

The AGM re-elected PricewaterhouseCoopers Oy, Authorized Public Accountants,
as the company's auditors with Juha Tuomala, Authorized Public Accountant,
acting as the principal auditor.

The AGM decided to accept the Board's proposal on profit distribution,
according to which the profit for the financial period, EUR 2,056,691.01, will
be added to retained earnings, and a dividend of EUR 0.02 per share will be
paid, totaling EUR 1,531,342.42.

The AGM authorized the Board to make the decision to buy back a maximum of
7,688,973 of the company's own shares, in one or more installments, using the
company's unrestricted equity, in which case any buyback will reduce the
amount of company distributable earnings.

The AGM cancelled the Board of Directors' valid unexercised share-issue
authorizations, and authorized the Board to decide to issue a maximum of
30,000,000 shares or to grant special rights (including stock options)
entitling to shares, as referred to in Section 1 of Chapter 10 of the Limited
Liability Companies Act, in one or several tranches. This authorization was
granted to be used to finance and implement any prospective corporate
acquisitions or other transactions, to implement the company's share-based
incentive plans, or for other purposes determined by the Board. The Board has
the right to decide on all terms and conditions governing said share issue and
the granting of special rights, including the subscribers or grantees of the
special rights, and the consideration payable. The Board's authorization
includes the right to waive shareholders' preemptive subscription rights and
covers the issue of new shares and the transfer of any shares that may be held
by the company. This authorization will be valid until April 30, 2013.

BOARD OF DIRECTORS AND AUDITORS

Since March 28, 2012, Revenio Group Corporation's Board of Directors has
included Timo Mänty, M.Econ, Managing Director of Onninen Oy (Chairman of the
Board), Pekka Tammela, M.Econ, Authorized Public Accountant, partner in
Pajamaa Partners Oy, Rolf Fryckman, optician, Chairman of Eyemaker's Finland
Oy, Matti Hyytiäinen, M.Econ, Managing Director of PKC Group Oyj, and Julia
Ormio, Senior Legal Counsel at Foster Wheeler Energy Oy.

PricewaterhouseCoopers Oy, Authorized Public Accountants, serves as the
company's auditor, with Juha Tuomala, Authorized Public Accountant, as the
principal auditor.

In 2012, the Board of Directors met 18 times. On average, Board members'
meeting attendance rate was 97.7 percent.

In accordance with the AGM's decision, 40 percent of Board members'
emoluments, in total, were settled in the form of shares in the company, while
60 percent consisted of monetary payment. In the course of the financial year,
the company made, in total, EUR 122,653.35 in monetary payments as Board
emoluments. In addition, 226,667 Revenio Group Corporation shares in all were
granted as Board emoluments.

In the 2012 financial year, the President and CEO was paid EUR 260,278.19 in
salary.

MAJOR BUSINESS RISKS AND UNCERTAINTIES

Revenio Group's risks are defined as strategic, operational, trade cycle,
hazard, and financial risks.

The Group's strategic risks include competition in all sectors, the threat
posed by new competing products, and any other actions of the company's rivals
that may affect the competitive situation. Another factor posing a strategic
risk is related to success in R&D operations and, therefore, preservation of
the product range's competitiveness. In the Group's sectors, requiring
particular expertise in accordance with the strategy, essential risks also
include those related to the retention and development of key personnel as
well as dependence on the operational ability of the subcontractor and
supplier network.

Corporate acquisitions are part of the Group's strategy. The success of these
acquisitions has a significant impact on the reaching of growth and
profitability targets. Acquisitions may also change the Group's risk profile.

Strategic risks and the need for action are regularly assessed and are
monitored in connection with day-to-day management, monthly Group reporting,
and annual strategy updates.

Operational risks are associated with the retention and development of major
customers, the operations of the distribution network and success in extending
the customer base and markets. In the Revenio Health Tech segment especially,
operational risks include factors related to expansion into new markets, such
as various countries' regulation of sales licenses for medical instruments
imposed at national level and the related official decisions concerning the
health care market.

The operational risks related to the manufacture, product development, and
production control of medical instruments are estimated to be higher than
average in the Revenio Health Tech segment, because of that sector's
requirements concerning quality.

Project-based operations, mainly carried out in the Revenio Technology and
Services segment, involve exposure to operational risks related to the
management of demanding end-to-end deliveries, which may concern the company's
own project work, subcontractors and suppliers.

The share of deferred tax assets in the assets item of the consolidated
balance sheet is significant. Changes in business profitability and in both
tax legislation and its interpretation could lead to changes in the
availability and amount of deferred tax assets.

Hazard risks are covered by insurances. Property insurance and insurance
against interruptions to business provide protection against risks in these
areas. The business pursued is covered by international liability insurances.

Financial risks consist of credit, interest, liquidity, and foreign exchange
risks. To manage credit loss risks, the Group has taken out credit insurance
covering all companies in the Group. Every month, and more frequently if
necessary, the Board, in its meetings, assesses matters related to financial
issues. If required, the Board provides decisions and guidelines for the
management of financial risks concerning interest-rate and currency hedging,
for instance. The liquidity risk can be affected by the availability of
external financing, the development of the Group's credit standing, the trend
in business operations and changes in the payment behavior of customers.
Liquidity risks are monitored by means of cash forecasts, which are drawn up
for periods of 12 months at most at a time.

MAJOR EVENTS AFTER THE PERIOD

The company's number of shares rose to 77,110,790 on January 31, 2013 due to
the subscription of a total of 181,060 shares with 2007 B and C options.

Done Logistics Oy, which is categorized under discontinued operations,
divested part of its business operations to Amipac Oy on February 7, 2013. The
transaction did not have a significant effect on the Group's financial
position.

OUTLOOK FOR 2013

In continuing operations, consolidated net sales and operating profit
excluding non-recurring items are expected to see year-on-year growth.

THE BOARD'S PROPOSAL TO THE ANNUAL GENERAL MEETING

The consolidated net profit for the year totaled EUR -287 thousand and that of
the parent company EUR 1,545,444.10. The parent company's distributable
earnings on December 31, 2012 totaled EUR 14,469,251.77. The Board of
Directors will propose to the Annual General Meeting on March 21, 2013, that
the parent company's distributable earnings be allocated as follows:

- A per-share dividend of EUR 0.02, for a total of 1,536,675.74, against the
total number of shares on the balance sheet date, will be distributed.

- in addition, the Board of Directors proposes that the Annual General Meeting
authorize the Board of Directors to distribute funds to shareholders, at its
own discretion, as a capital repayment from the invested unrestricted equity
reserve. The maximum amount of funds that can be distributed on the basis of
the authorization would be EUR 1,000,000.00.

The rest of the distributable retained earnings will be entered under equity.

In the Board's opinion, the proposed dividend distribution does not endanger
the parent company's or Group's liquidity.

STATEMENT OF ACCOUNTING POLICIES

The recognition and valuation principles underlying the financial information
presented in this Interim Report comply with the principles of the
International Financial Reporting Standards (IFRS). The report does not comply
with all the requirements of IAS 34, Interim Financial Reporting. These
financial statements are based on audited figures.

GROUP KEY FIGURES AND RATIOS (MEUR)                       1-12/2012  1-12/2011
Net sales, continuing operations                               25.4       21.4
Ebitda, continuing operations                                   5.7        4.0
Ebitda-%, continuing operations                                22.5       18.8
Operating profit, continuing operations                         4.9        3.3
Operating profit-%, continuing operations                      19.4       15.6
Pre-tax profit, continuing operations                           4.7        3.0
Pre-tax profit-%, continuing operations                        18.5       14.0
Net profit from discontinued operations                        -4.8        1.8
Net profit                                                     -0.3        2.1
Net profit-%                                                   -1.1        8.3
Gross capital expenditure                                       0.3        0.7
Gross capital expenditure-%                                     1.1        3.3
R&D costs                                                       0.4        0.4
R&D costs-% from net sales                                      1.4        1.9
Gearing-%                                                     -12.2      -17.3
Equity ratio-%                                                 62.2       66.6
Return on investment-% (ROI)                                    0.4       20.2
Return on equity-% (ROE)                                       -1.8       14.1
Undiluted earnings per share, EUR, continuing operations      0.059      0.028
Diluted Earnings per share, EUR, continuing operations        0.059      0.027
Undiluted earnings per share, EUR, discontinued
operations                                                   -0.063      0.023
Diluted Earnings per share, EUR, discontinued operations     -0.063      0.023
Equity per share, EUR                                          0.19       0.21
Average no. of employees, continuing operations                 198        201
Cash flow from operating activities                             0.8        4.2
Cash flow from investing activities                            -0.1        1.1
Net cash used in financing activities                          -0.2       -3.0
Total cash flow                                                 0.5        2.4

CONSOLIDATED COMPREHENSIVE                                1-12/2012  1-12/2011
INCOME STATEMENT (MEUR)
NET SALES                                                      25.4       21.4
Other operating income                                          0.1        0.1
Materials and services                                         -6.9       -5.5
Employee benefits                                              -8.4       -8.0
Depreciation/amortization                                      -0.8       -0.7
Other operating expenses                                       -4.5       -4.0
OPERATING PROFIT, CONTINUING OPERATIONS                         4.9        3.3
Share of associates' results                                    0.0        0.0
Financial expenses (net)                                       -0.2       -0.3
PRE-TAX PROFIT, CONTINUING OPERATIONS                           4.7        3.1
Income tax expense                                             -0.1       -0.9
Net profit from continuing operations                           4.6        2.1
Net profit from discontinued operations                        -4.8        1.8
NET PROFIT                                                     -0.3        3.9
Other comprehensive income items                                0.0        0.0
Income tax expense for comprehensive income                     0.0        0.0
Other comprehensive income items
after taxes                                                     0.0        0.0
TOTAL COMPREHENSIVE INCOME                                     -0.3        3.9
Net profit attributable to:
Parent company shareholders                                    -0.3        3.9
Total comprehensive income attributable to:
Parent company shareholders                                    -0.3        3.9
Earnings per share, undiluted,EUR, continuing operations      0.059      0.028
Earnings per share, diluted,EUR, continuing operations        0.059      0.027
Earnings per share, undiluted,EUR, discontinued
operations                                                   -0.063      0.023
Earnings per share, diluted,EUR, discontinued operations     -0.063      0.023

CONSOLIDATED COMPREHENSIVE
INCOME STATEMENT (MEUR)                     10-12/2012 10-12/2011
NET SALES                                       7.7           5.7
Other operating income                          0.0           0.0
Materials and services                         -2.5          -1.3
Employee benefits                              -2.3          -2.3
Depreciation/amortization                      -0.3          -0.1
Other operating expenses                       -1.2          -0.9
OPERATING PROFIT, CONTINUING OPERATIONS         1.4           1.1
Share of associates' results                    0.0           0.0
Financial expenses (net)                        0.0          -0.2
PRE-TAX PROFIT, CONTINUING OPERATIONS           1.4           0.9
Income tax expense                              0.1          -0.4
Net profit from continuing operations           1.4           0.5
Net profit from discontinued operations        -2.1           0.2
NET PROFIT                                     -0.6           0.7
Other comprehensive income items                0.0           0.0
Income tax expense for comprehensive income     0.0           0.0
Other comprehensive income items
after taxes                                     0.0           0.0
TOTAL COMPREHENSIVE INCOME                     -0.6           0.7
Net profit attributable to:
Parent company shareholders                    -0.6           0.7
Total comprehensive income attributable to:
Parent company shareholders                    -0.6           0.7

CONSOLIDATED BALANCE SHEET (MEUR)  
                                     31 Dec 2012          31 Dec 2011
ASSETS
NON-CURRENT ASSETS
Property. plant and equipment                  1.6                  1.6
Goodwill                                       8.1                  8.1
Intangible assets                              0.6                  1.0
Shares in associates                           0.0                  0.3
Deferred tax assets                            1.6                  1.8
TOTAL NON-CURRENT ASSETS                      12.0                 12.8
CURRENT ASSETS
Inventories                                    1.3                  1.0
Trade and other receivables                    4.8                  3.3
Cash and cash equivalents                      5.0                  4.5
TOTAL CURRENT ASSETS                          11.2                  8.9
Non-current assets held
for sale                                       1.8                  3.1
TOTAL ASSETS                                  25.0                 24.8
LIABILITIES AND SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY
Share capital                                  5.3                  5.3
Share premium                                  2.4                  2.4
Fair value reserve                             0.3                  0.3
Invested unrestricted capital reserve          7.1                  7.0
Retained earnings/loss                        -0.4                  1.4
TOTAL EQUITY. attributable to holders
of parent company equity                      14.7                 16.4
TOTAL SHAREHOLDERS' EQUITY                    14.7                 16.4
LIABILITIES
NON-CURRENT LIABILITIES
Deferred tax liabilities                       0.2                  0.3
Provisions                                     0.1                  0.1
Financial liabilities                          1.4                  0.4
TOTAL LONG-TERM LIABILITIES                    1.7                  0.8
CURRENT LIABILITIES
Advance payments                               1.4                  0.1
Trade and other payables                       3.3                  4.0
Financial liabilities                          1.8                  1.1
TOTAL SHORT-TERM LIABILITIES                   6.5                  5.1
Long-term liabilities held
for sale                                       2.1                  2.5
TOTAL LIABILITIES                             10.3                  8.4
TOTAL LIABILITIES AND
SHAREHOLDERS' EQUITY                          25.0                 24.8
CONSOLIDATED STATEMENT OF CHANGE IN EQUITY (MEUR)
                           Share       Share       Other    Retained    Total
                        capital     Premium     Reserves Earnings    Equity
Balance 1 Jan 2012         5.3         2.4         7.3      1.3         16.4
Dividend distribution      0.0         0.0         0.0      -1.5        -1.5
Options expense
adjustment                 0.0         0.0         0.0      0.1         0.1
Net profit                 0.0         0.0         0.0      0.3         0.3
Balance 31 Dec 2012        5.3         2.4         7.3      -0.4        14.7
                           Share       Share       Other    Retained    Total
                           capital     Premium     Reserves Earnings    Equity
Balance 1 Jan 2011         5.3         2.4         7.3      -1.0        14.1
Dividend distribution      0.0         0.0         0.0      -1.5        -1.5
Own shares purchased       0.0         0.0         0.0      -0.2        -0.2
Options expense
adjustment                 0.0         0.0         0.0      0.1         0.1
Net profit                 0.0         0.0         0.0      3.9         3.9
Balance 30 Sept 2011       5.3         2.4         7.3      1.3         16.4

CONSOLIDATED CASH FLOW STATEMENT (MEUR) 1-12/2012  1-12/2011
Net profit                                   -0.3        3.9
Adjustments to net profit                     1.2        1.9
Change in working capital                    -0.1       -1.6
Interest paid                                -0.1        0.0
Interest received                             0.0        0.0
CASH FLOW FROM OPERATING ACTIVITIES           0.8        4.2
Sales of subsidiaries
and associates' shares (net)                  0.2        1.7
Purchase of PPE                              -0.2       -0.5
Purchase of Intangible assets                 0.0        0.0
NET CASH USED IN INVESTING ACTIVITIES        -0.1        1.1
Purchase of own shares                        0.0       -0.2
Paid dividends                               -1.5       -1.5
Repayments of long-term borrowings           -1.7       -1.2
Long-term loans received                      3.2        0.0
Finance lease principal payment              -0.1       -0.1
NET CASH USED IN FINANCING ACTIVITIES        -0.2       -3.0
Net change in cash and equivalents            0.5        2.4
Cash and equivalents. period-start            4.4        2.1
Cash and equivalents. period-end              5.0        4.4

NET SALES AND OPERATING PROFIT BY
QUARTER (MEUR)
             Q4/2012  Q3/2012  Q2/2012 Q1/2012 Q4/2011 Q3/2011 Q2/2011 Q1/2011
Net sales        7.7      6.1      5.8     5.8     5.7     4.6     5.6     5.6
Oper.
Profit           1.4      1.4      1.0     1.2     0.7     1.0     0.8     0.8
Oper.
profit.-%         18       23       17      20      13      21      15      15

MAIN SHAREHOLDERS 31 Dec 2012
                                        No. of shares     %
1. Merivirta Jyri                          10,000,000  13 %
2. Eyemakers' Finland Oy                    5,000,000   6 %
3. Sijoitusrahasto Evli Suomi Osake         3,710,767   5 %
4. Keskinäinen Eläkevakuutusyhtiö Etera     3,500,000   5 %
5. Gerako Oy                                3,400,000   4 %
6. Alpisalo Mia                             2,948,153   4 %
7. Joensuun Kauppa ja Kone Oy               2,700,000   4 %
8. Kirkon Keskusrahasto                     1,240,810   2 %
9. AJP Holding Oy                           1,000,000   1 %
10. Kiesvaara Tuomo                           901,230   1 %

Revenio Group Corporation

Board of Directors

For additional information:

President & CEO Olli-Pekka Salovaara, GSM +358 (0)40 5675520

olli-pekka.salovaara@revenio.fi

http://www.revenio.fi

DISTRIBUTION:

NASDAQ OMX Helsinki

Financial Supervisory Authority (FIN-FSA)

Principal media

www.revenio.fi

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Revenio Group Corporation via Thomson Reuters ONE
HUG#1676546
 
Press spacebar to pause and continue. Press esc to stop.